{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:49:20Z","timestamp":1760237360965,"version":"build-2065373602"},"reference-count":26,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T00:00:00Z","timestamp":1589068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Varicella is a highly contagious, infectious disease caused by the varicella-zoster virus. Those at higher risk of severe complications are immunocompromised individuals, adults, non-immune pregnant women, and newborns. According to the gestational time, when varicella-zoster virus infection is acquired during pregnancy, serious complications can potentially occur for both the woman and the fetus. The present study was conducted to assess the profile of varicella susceptibility in pregnant women in Apulia, a large region in Southern Italy, from 2016 to 2019. The data showed that pregnant women between the age of 15\u201324 and 40\u201349 years, the youngest and the oldest, respectively, are the most protected against varicella-zoster virus infection, exceeding the prevalence rate of 90%. Conversely, pregnant women between the age of 25 and 34 years seem to be the most vulnerable and the most at risk for acquiring varicella-zoster virus infection during pregnancy. Analysis of the immunity status against varicella should be introduced as a screening test before pregnancy, together with a strategic vaccination campaign targeting non-immune women of childbearing age, in order to reduce the risk of congenital and perinatal varicella.<\/jats:p>","DOI":"10.3390\/vaccines8020214","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T10:01:18Z","timestamp":1589191278000},"page":"214","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of Varicella Immunity during Pregnancy in Apulia Region, Southern Italy"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7229-9919","authenticated-orcid":false,"given":"Claudia M.","family":"Trombetta","sequence":"first","affiliation":[{"name":"Department of Molecular and Developmental Medicine, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Montomoli","sequence":"additional","affiliation":[{"name":"Department of Molecular and Developmental Medicine, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy"},{"name":"VisMederi srl, Strada del Petriccio e Belriguardo 35, 53100 Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simonetta","family":"Viviani","sequence":"additional","affiliation":[{"name":"Department of Molecular and Developmental Medicine, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Coluccio","sequence":"additional","affiliation":[{"name":"Department of Molecular and Developmental Medicine, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6817-2461","authenticated-orcid":false,"given":"Serena","family":"Marchi","sequence":"additional","affiliation":[{"name":"Department of Molecular and Developmental Medicine, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,5,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1017\/S0950268801005398","article-title":"The seroepidemiology of varicella in Italy","volume":"126","author":"Gabutti","year":"2001","journal-title":"Epidemiol. Infect."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1080\/21645515.2017.1264828","article-title":"Has VZV epidemiology changed in Italy? Results of a seroprevalence study","volume":"13","author":"Kuhdari","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_3","unstructured":"World Health Organization (2014). Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly. Epidemiol. Rec., 89, 265\u2013288."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1016\/j.vaccine.2014.08.088","article-title":"A seroprevalence survey on varicella among adults in the vaccination era in Apulia (Italy)","volume":"32","author":"Tafuri","year":"2014","journal-title":"Vaccine"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Narkeviciute, I., and Bernatoniene, J. (2012). Varicella Zoster Virus Infection in Pregnancy. Herpesviridae\u2014A Look into This Unique Family of Viruses, IntechOpen. George Dimitri Magel, Stephen K. Tyring.","DOI":"10.5772\/31171"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/14767058.2010.497567","article-title":"The prevalence of congenital varicella syndrome after a maternal infection, but before 20 weeks of pregnancy: A prospective cohort study","volume":"24","author":"Sanchez","year":"2011","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e000433","DOI":"10.1136\/bmjpo-2019-000433","article-title":"Management of varicella in neonates and infants","volume":"3","author":"Blumental","year":"2019","journal-title":"BMJ Paediatr. Open"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00430-006-0032-z","article-title":"Herpes simplex and varicella-zoster virus infections during pregnancy: Current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections","volume":"196","author":"Sauerbrei","year":"2007","journal-title":"Med. Microbiol. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199403313301305","article-title":"Outcome after maternal varicella infection in the first 20 weeks of pregnancy","volume":"330","author":"Pastuszak","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/pd.3843","article-title":"Fetal varicella\u2014diagnosis, management, and outcome","volume":"32","author":"Mandelbrot","year":"2012","journal-title":"Prenat. Diagn."},{"key":"ref_11","unstructured":"Ministero Della Salute (2020, March 17). Vaccinazioni. Legge Vaccini, Available online: http:\/\/www.salute.gov.it\/portale\/vaccinazioni\/dettaglioContenutiVaccinazioni.jsp?lingua=italiano&id=4824&area=vaccinazioni&menu=vuoto%20Piano%20Nazionale%20Prevenzione%20Vaccinale%20PNPV%202017-2019."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.vaccine.2018.01.065","article-title":"The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900-2015","volume":"36","author":"Pezzotti","year":"2018","journal-title":"Vaccine"},{"key":"ref_13","unstructured":"Osservatorio Epidemiologico Regionale\u2014Puglia (2012). RELAZIONE SULLO STATO DI SALUTE DELLA POPOLAZIONE PUGLIESE. ANNI 2006\u20132011. Mal. Infett. Vaccinazioni, 5, 247\u2013256."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4161\/hv.36153","article-title":"Effectiveness of vaccination against varicella in children under 5 years in Puglia, Italy 2006-2012","volume":"11","author":"Tafuri","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1080\/21645515.2019.1621146","article-title":"Measles in pregnancy: A threat for Italian women?","volume":"15","author":"Marchi","year":"2019","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcv.2011.10.007","article-title":"Susceptibility to varicella-zoster among pregnant women in the province of Lecce, Italy","volume":"53","author":"Guido","year":"2012","journal-title":"J. Clin. Virol."},{"key":"ref_17","unstructured":"National Institutes of Health (2020, March 16). About Pregnancy, Available online: https:\/\/www.nichd.nih.gov\/health\/topics\/pregnancy\/conditioninfo."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2007.05.019","article-title":"Susceptibility to varicella in childbearing age women, Central Italy: Is there a need for vaccinating this population group?","volume":"25","author":"Alfonsi","year":"2007","journal-title":"Vaccine"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1017\/S0950268807008497","article-title":"The seroepidemiology of varicella zoster virus among pregnant Bangladeshi and white British women in the London Borough of Tower Hamlets, UK","volume":"135","author":"Talukder","year":"2007","journal-title":"Epidemiol. Infect."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s42506-018-0002-5","article-title":"Seroprevalence of varicella-zoster virus among pregnant women in Fayoum Governorate, Egypt","volume":"94","author":"Ibrahim","year":"2019","journal-title":"J. Egypt. Public Health Assoc."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Mirinaviciute, G., Barlinn, R., Dudman, S.G., and Flem, E. (2019). Immunity to varicella zoster virus among pregnant women in the Norwegian Mother and Child Cohort Study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0221084"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Premathilake, I.P., Aluthbaduge, P., Senanayake, C.P., Jayalatharachchi, R., Gamage, S., and Jayamaha, J. (2019). Susceptibility for varicella and factors associated with immunity among pregnant women in a tertiary care hospital in Sri Lanka- a cross-sectional study. BMC Infect. Dis., 19.","DOI":"10.1186\/s12879-019-3996-1"},{"key":"ref_23","unstructured":"European Commission (2017). Women are Having Their First Child at an Older Age, European Commission."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1080\/21645515.2019.1688041","article-title":"Elimination of congenital rubella: A seroprevalence study of pregnant women and women of childbearing age in Italy","volume":"16","author":"Marchi","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_25","first-page":"1","article-title":"Advisory Committee on Immunization Practices, Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1086\/522136","article-title":"Varicella vaccine exposure during pregnancy: Data from 10 Years of the pregnancy registry","volume":"197","author":"Wilson","year":"2008","journal-title":"J. Infect. Dis."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/2\/214\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:27:20Z","timestamp":1760174840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/2\/214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,10]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["vaccines8020214"],"URL":"https:\/\/doi.org\/10.3390\/vaccines8020214","relation":{},"ISSN":["2076-393X"],"issn-type":[{"type":"electronic","value":"2076-393X"}],"subject":[],"published":{"date-parts":[[2020,5,10]]}}}